BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pae CU, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS. Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study. Clin Psychopharmacol Neurosci 2020;18:153-8. [PMID: 31958916 DOI: 10.9758/cpn.2020.18.1.153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Pae CU. Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not? Chonnam Med J 2020;56:157-65. [PMID: 33014754 DOI: 10.4068/cmj.2020.56.3.157] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pae CU, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS. Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not? Clin Psychopharmacol Neurosci 2021;19:434-48. [PMID: 34294613 DOI: 10.9758/cpn.2021.19.3.434] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Pae CU, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS. Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study. Clin Psychopharmacol Neurosci 2021;19:233-42. [PMID: 33888652 DOI: 10.9758/cpn.2021.19.2.233] [Reference Citation Analysis]